BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 5765127)

  • 1. Bilateral ureteral obstruction after the administration of allopurinol to a patient with renal pelvic urate calculi.
    Steel K
    South Med J; 1969 Mar; 62(3):314 passim. PubMed ID: 5765127
    [No Abstract]   [Full Text] [Related]  

  • 2. [Uric acid inhibitors in the treatment of gout. Apropos of 126 cases].
    Serre H; Simon L; Claustre J
    Sem Hop; 1970 Dec; 46(50):3295-301. PubMed ID: 4323560
    [No Abstract]   [Full Text] [Related]  

  • 3. [Inhibition of endogenous synthesis of uric acid with allopurinol in patients with gout and urate diathesis].
    Holländer E; Schwarczmann P
    Munch Med Wochenschr; 1969 Aug; 111(32):1623-6. PubMed ID: 5394966
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyperuricemia and gout.
    Lo B
    West J Med; 1985 Jan; 142(1):104-7. PubMed ID: 3976216
    [No Abstract]   [Full Text] [Related]  

  • 5. [Long-term therapy of gout and hyperuricemia].
    Heidelmann G
    Z Gesamte Inn Med; 1973 Mar; 28(5):76-80. PubMed ID: 4705902
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hyperuricemia and gout--treatment].
    Gröbner W; Walter-Sack I
    Dtsch Med Wochenschr; 2002 Feb; 127(5):210-3. PubMed ID: 11821994
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of decrease in hyperuricemia levels on joint, kidney and other symptoms in patients with gout].
    Kawenoki-Minc E
    Ter Arkh; 1987; 59(4):25-8. PubMed ID: 3589999
    [No Abstract]   [Full Text] [Related]  

  • 8. [The inhibition of uric acid synthesis with Allopurinol].
    Holländer E
    Orv Hetil; 1968 Oct; 109(41):2272-4. PubMed ID: 5715143
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of the gout and other forms of crystal-induced arthritis.
    Rodnan GP
    Bull Rheum Dis; 1982; 32(5):43-53. PubMed ID: 6762236
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
    Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
    Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gout and uric acid metabolism.
    Arthritis Rheum; 1970; 13(5):553-69. PubMed ID: 4922854
    [No Abstract]   [Full Text] [Related]  

  • 12. Allopurinol dissolution of renal uric acid calculi.
    Wasko R; Frankenfield BA
    JAMA; 1968 Sep; 205(11):801. PubMed ID: 5695296
    [No Abstract]   [Full Text] [Related]  

  • 13. [Allopurinol in the treatment of gout and uric acid nephrolithiasis].
    Zöllner N; Schattenkirchner M
    Dtsch Med Wochenschr; 1967 Apr; 92(14):654-60. PubMed ID: 6024539
    [No Abstract]   [Full Text] [Related]  

  • 14. Hyperuricemia and gout.
    Sloan RW
    J Fam Pract; 1982 May; 14(5):923-6, 930-1, 934. PubMed ID: 7042900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Allopurinol treatment of patients with uric acid calculi].
    Frang D; Berényi M; Végh A
    Acta Chir Acad Sci Hung; 1973; 14(2):105-11. PubMed ID: 4751148
    [No Abstract]   [Full Text] [Related]  

  • 16. Allopurinol in treatment of patients with gout and chronic renal failure.
    Bowie EA; Simmonds HA; North JD
    N Z Med J; 1967 Sep; 66(421):606-11. PubMed ID: 5234549
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of allopurinol in gout, hyperuricemia and uric acid lithiasis.
    Blechman WJ; Rosenberg DG; Hilf P
    South Med J; 1967 Feb; 60(2):215-8. PubMed ID: 6016656
    [No Abstract]   [Full Text] [Related]  

  • 18. [Modern therapy of gout].
    Otto W; Häntzschel H
    Beitr Rheumatol; 1972; 18():89-95. PubMed ID: 4649126
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of gout and hyperuricemia.
    Wisner DE; Simkin PA
    Prim Care; 1984 Jun; 11(2):283-94. PubMed ID: 6206519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher therapeutic plasma oxypurinol concentrations might be required for gouty patients with chronic kidney disease.
    Panomvana D; Sripradit S; Angthararak S
    J Clin Rheumatol; 2008 Feb; 14(1):6-11. PubMed ID: 18431090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.